Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,627 signal articles · 58 in last 24h · 155,662 total before filter · latest 45m ago
58last 24h
846last 7d
141● bullish (7d)
89● bearish (7d)
214publishers
AllMacro196Earnings105M&A122Regulatory20Product21Analyst19
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Baylin Technologies Backlog Hits Record C$61M After Kaelus Acquisition
MarketBeat35d agoneutral
Baylin Technologies Backlog Hits Record C$61M After Kaelus Acquisition

Baylin Technologies (TSE:BYL) reported a record backlog of C$61 million in firm purchase orders following its acquisition of Kaelus, as the company seeks to expand its wireless infrastructure, satellite communications and custom antenna businesses. Chief Executive Officer Leighton Carroll said the

Forkast News35d agoneutral
Nvidia’s $7 Billion Poolside Deal Reveals a Licensing Playbook That Sidesteps Acquisition Scrutiny

Nvidia is effectively centralizing the artificial intelligence supply chain by bypassing traditional mergers and acquisitions in favor of a repeatable, non-traditional financial mechanism. By deploying a licensing-plus-hire strategy, the company absorbs the operational capacity of critical AI startups while avoiding the regulatory scrutiny that typically accompanies full-scale corporate integration. This approach, most recently evidenced by […]

OBOOK Q2 Earnings Call Highlights
MarketBeat35d agoneutral
OBOOK Q2 Earnings Call Highlights

OBOOK (NASDAQ:OWLS), which operates under the OwlTing Group brand, said its first-half 2026 results reflected a transition from building stablecoin-enabled payments infrastructure to commercializing its OwlPay cross-border settlement platform. Management said the company’s reported financial result

Moderna, Merck Cancer Vax Gives Hope
Bloomberg35d agoneutralVIDEO
Moderna, Merck Cancer Vax Gives Hope

Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy cancer cells. News that an mRNA cancer vaccine developed by Merck & Co. and Moderna Inc. kept melanoma from returning in a large, late-stage trial marks a critical next chapter for a technology beleaguered by post-pandemic political backlash and years of false starts before then. Bloomberg Opinion Columnist Lisa Jarvis writes "Moderna and Merck's Cancer Vaccine Is a Marvel."

Copper Demand Pushes Freeport-McMoRan to Record
The Wall Street Journal35d agoneutral
Copper Demand Pushes Freeport-McMoRan to Record

Surging copper demand sent Freeport-McMoRan to a new all-time closing high Friday, based on data back to 1995. Share prices closed at $76.66, up 7.6%. Year-to-date, shares are up 51%. Copper has surged as a must-have for the AI buildout and because of U.

SEC charges former Bank of America investment banker with insider trading
Reuters35d agoneutral
SEC charges former Bank of America investment banker with insider trading

The U.S. Securities and Exchange Commission on Friday charged a former senior Bank of America investment banker with insider trading, ‌alleging he tipped a longtime friend and former colleague about a pending merger, allowing ‌the friend to make $18.5 million of illegal profit. Jason Satsky, who was Bank of America’s co-head of Americas power and renewable ​energy banking, allegedly tipped Gavin Wolfe in late 2021 about the potential acquisition of South Jersey Industries, an energy holding company that the bank was advising. The SEC said Wolfe, who runs the firm Evergreen Capital and has been Satsky's friend for more than 20 years, bought more than 2.2 million ‌shares of the South Jersey Gas ⁠parent worth about $53 million, and realized a 36% gain after the company announced an $8.1 billion buyout on February 24, 2022.

This Market Barometer Is Sending a Warning Sign
Barrons.com35d agoneutral
This Market Barometer Is Sending a Warning Sign

Vestmo, a quantitative research firm we track at the Barron’s Investor Circle, sent an update on its market barometer on Friday. The barometer takes into account seven different factors, including things such as earnings variability and price momentum. Vestmo noted higher rates, rising oil prices, and a “less supportive” Federal Reserve that is more likely to hike interest rates than cut them are among the drivers of the more risk-off stance.

Investing.com36d agoneutral
Investing.com’s stocks of the week

Investing.com -- A historic single-day move in biotech dominated the week, while a Treasury liquidity announcement impacted crypto and metals. Two well-known consumer names went in opposite directions on earnings.